课题基金 / 基金详情

SAFETY OF COMBINED INSULIN AND SULFONYLUREA THERAPY FOR TYPE II DIABETES

SAFETY OF COMBINED INSULIN AND SULFONYLUREA THERAPY FOR TYPE II DIABETES
胰岛素和磺脲类联合疗法治疗 II 型糖尿病的安全性
批准号：
3850299
负责人：
MATTHEW C RIDDLE
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3850299
关键词：
combination chemotherapy diabetes mellitus therapy exercise fasting glucose metabolism glucose tolerance test human subject human therapy evaluation hypoglycemia insulin noninsulin dependent diabetes mellitus sulfonylurea

项目摘要

项目成果

MATTHEW C RIDDLE的其他基金

相关文献

中文摘要
翻译
临床研究表明，胰岛素-磺脲类药物联合治疗可能有效
英文摘要
Clinical studies suggest combined insulin-sulfonylurea therapy may yield less glycemic variability than insulin alone. This CRC protocol studies this concept by comparing the two regimens with respect to 1) glycemic variability over 24 hours, and 2) tendency to hypoglycemia with fasting plus mild exercise. Ten subjects will be studied in a crossover design, with two 3-day stays in the CRC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RISK OF HYPOGLYCEMIA WITH MORNING VS BEDTIME NPH INSULIN FOR TYPE II DIABETES
INSULIN REGIMEN FOR PATIENTS WITH NON-OBESE TYPE-II DIABETES MELLITUS
SAFETY OF COMBINED INSULIN AND SULFONYLUREA THERAPY FOR TYPE II DIABETES
STEROID DIABETES--METABOLIC PATTERNS AND BASIS FOR TREATMENT